系统综述与荟萃分析:视频内镜时代(1990年至今)炎症性肠病相关结肠异型增生的预后
该系统综述与荟萃分析检索1990年至2020年2月发表的原始文献,纳入33项研究进行定性分析(其中5项进入荟萃分析),评估视频内镜时代诊断的炎症性肠病相关异型增生患者同步结直肠癌及异时性进展期肿瘤的风险,并按病变形态、内镜切除状态及是否在肉眼正常黏膜活检中偶然发现进行风险分层。
要点
- 因术前诊断可见高级别异型增生而行结肠切除术时,同期发现偶发癌的合并估计比例为13.7%(95%CI 0.0-54.1)。
- 不可见高级别异型增生、可见低级别异型增生、不可见低级别异型增生对应的同期偶发癌合并估计比例分别为11.4%(95%CI 4.6-20.3)、2.7%(95%CI 0.0-7.1)、2.4%(95%CI 0.0-8.5)。
- 采用高清成像和/或色素内镜、且可见异型增生的内镜切除经组织学确认的研究,倾向于报告最低的异时性进展期肿瘤发生率。
核心结论
- 视频内镜时代诊断的炎症性肠病相关异型增生的预后似乎有所改善,但证据质量仍低。
- 需要更大规模的前瞻性研究来指导管理。
研究设计与样本
- 系统检索1990年至2020年2月发表的原始文章。
- 33项研究符合定性分析条件,其中5项进入荟萃分析。
- 纳入研究报告了炎症性肠病相关异型增生患者在随访结肠切除术或结肠镜检查时进展期肿瘤的发生率。
主要发现
- 因术前诊断可见高级别异型增生而行结肠切除术时,同期发现偶发癌的合并估计比例为13.7%(95%CI 0.0-54.1)。
- 因术前诊断不可见高级别异型增生而行结肠切除术时,同期发现偶发癌的合并估计比例为11.4%(95%CI 4.6-20.3)。
- 因术前诊断可见低级别异型增生而行结肠切除术时,同期发现偶发癌的合并估计比例为2.7%(95%CI 0.0-7.1)。
- 因术前诊断不可见低级别异型增生而行结肠切除术时,同期发现偶发癌的合并估计比例为2.4%(95%CI 0.0-8.5)。
- 对于未立即行结肠切除术而接受监测随访的异型增生,采用高清成像和/或色素内镜且可见异型增生的内镜切除经组织学确认的研究,倾向于报告最低的异时性进展期肿瘤发生率。
局限性
- 证据质量仍低。
- 需要更大规模的前瞻性研究来指导管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The prognosis of dysplasia in patients with IBD is largely determined from observational studies from the pre-videoendoscopic era (pre-1990s) that does not reflect recent advances in endoscopic imaging and resection. AIMS: To better understand the risk of synchronous colorectal cancer and metachronous advanced neoplasia (ie high-grade dysplasia or cancer) associated with dysplasia diagnosed in the videoendoscopic era, and to stratify risk according to a lesion's morphology, endoscopic resection status or whether it was incidentally detected on biopsy of macroscopically normal colonic mucosa (ie invisible). METHODS: A systematic search of original articles published between 1990 and February 2020 was performed. Eligible studies reported on incidence of advanced neoplasia at follow-up colectomy or colonoscopy for IBD-dysplasia patients. Quantitative and qualitative analyses were performed. RESULTS: Thirty-three studies were eligible for qualitative analysis (five for the meta-analysis). Pooled estimated proportions of incidental synchronous cancers found at colectomy performed for a pre-operative diagnosis of visible high-grade dysplasia, invisible high-grade dysplasia, visible low-grade dysplasia and invisible low-grade dysplasia were 13.7% (95% CI 0.0-54.1), 11.4% (95% CI 4.6-20.3), 2.7% (95% CI 0.0-7.1) and 2.4% (95% CI 0.0-8.5) respectively. The lowest incidences of metachronous advanced neoplasia, for dysplasia not managed with immediate colectomy but followed up with surveillance, tended to be reported by the studies where high definition imaging and/or chromoendoscopy was used and endoscopic resection of visible dysplasia was histologically confirmed. CONCLUSIONS: The prognosis of IBD-dysplasia diagnosed in the videoendoscopic era appears to have been improved but the quality of evidence remains low. Larger, prospective studies are needed to guide management. PROSPERO registration no: CRD42019105736.
引用
- Kabir M, Fofaria R, Arebi N, et al. Systematic review with meta-analysis: IBD-associated colonic dysplasia prognosis in the videoendoscopic era (1990 to present). Aliment Pharmacol Ther. 2020. PMID: 32432797. doi:10.1111/apt.15778
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。